These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38909240)

  • 1. Survival outcomes of segmentectomy and lobectomy for early stage non-small cell lung cancer: a systematic review and meta-analysis.
    Li T; He W; Zhang X; Zhou Y; Wang D; Huang S; Li X; Fu Y
    J Cardiothorac Surg; 2024 Jun; 19(1):353. PubMed ID: 38909240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis.
    Tasoudis P; Loufopoulos G; Manaki V; Doerr M; Agala CB; Long JM; Haithcock BE
    Lung Cancer; 2024 Sep; 195():107929. PubMed ID: 39173232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Shi Y; Wu S; Ma S; Lyu Y; Xu H; Deng L; Chen X
    Ann Surg Oncol; 2022 Mar; 29(3):1868-1879. PubMed ID: 34613537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
    Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
    J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
    Winckelmans T; Decaluwé H; De Leyn P; Van Raemdonck D
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1051-1060. PubMed ID: 31898738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmentectomy vs Lobectomy for Early Non-Small Cell Lung Cancer With Visceral Pleural Invasion.
    Mathey-Andrews C; Abruzzo AR; Venkateswaran S; Potter AL; Senthil P; Beqari J; Yang CJ; Lanuti M
    Ann Thorac Surg; 2024 May; 117(5):1007-1014. PubMed ID: 37419171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.
    Hou B; Deng XF; Zhou D; Liu QX; Dai JG
    Ther Adv Respir Dis; 2016 Oct; 10(5):435-43. PubMed ID: 27585599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the oncologic outcomes of anatomic segmentectomy and lobectomy for early-stage non-small cell lung cancer.
    Zhang L; Li M; Yin R; Zhang Q; Xu L
    Ann Thorac Surg; 2015 Feb; 99(2):728-37. PubMed ID: 25497073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in Japan.
    Tane S; Okami J; Maniwa Y; Shintani Y; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
    Surg Today; 2024 Oct; 54(10):1162-1172. PubMed ID: 38635057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes of Lobectomy Versus Segmentectomy in Clinical Stage I Non-Small Cell Lung Cancer: A Meta-Analysis.
    Feng J; Wang LF; Han TY; Wang Y; Wu XY; Lv F; Liu Y; Chen BH
    Adv Ther; 2021 Jul; 38(7):4130-4137. PubMed ID: 34160757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
    Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical outcomes after thoracoscopic sublobectomy versus lobectomy for Stage I nonsmall cell lung cancer: A meta-analysis.
    Liu Q; Wang H; Zhou D; Deng X; Min J; Dai J
    J Cancer Res Ther; 2016; 12(2):926-31. PubMed ID: 27461676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system).
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Ose C; Weinreich G; Passlick B; Hecker E; Kugler C; Dienemann H; Krbek T; Eggeling S; Hatz R; Müller MR; Weder W; Aigner C; Jöckel KH
    Lung Cancer; 2019 Dec; 138():19-26. PubMed ID: 31606521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.
    Landreneau RJ; Normolle DP; Christie NA; Awais O; Wizorek JJ; Abbas G; Pennathur A; Shende M; Weksler B; Luketich JD; Schuchert MJ
    J Clin Oncol; 2014 Aug; 32(23):2449-55. PubMed ID: 24982447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.